Heart Test Laboratories Inc (HSCS)

Finanzdaten der Heart Test Laboratories Inc-Aktie (HSCS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	276.92% 0.0147	0.0039	-	-	0.00195
Cost Of Revenue	200.07% 0.00456	0.00152	-	-	0.00076
Gross Profit	326.01% 0.0101	0.00238	-	-	0.00119
Operating Expenses	2.34% 1.5355	1.5723	1.3307	1.5987	1.3105
Interest Income/Expense	33.62% 0.1184	0.1784	0.0363	0.034	0.0328
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	2.15% 1.5401	1.5738	1.3307	1.5987	1.3113
Operating Income/Loss	2.84% -1.5254	-1.5699	-1.3307	-1.5987	-1.3093
Nonoperating Income/Loss	33.63% -0.1184	-0.1784	-0.0362	-0.0337	-0.0328
Income/Loss From Continuing Operations Before Tax	276.92% 0.0147	0.0039	-1.3669	-	0.00195
Income/Loss From Continuing Operations After Tax	5.98% -1.6438	-1.7484	-1.3669	-1.6324	-1.3421
Net Income/Loss	5.98% -1.6438	-1.7484	-1.3669	-1.6324	-1.3421
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	391.75% 53.79	10.94	10.33	0.5788	8.2408
Diluted Average Shares	391.75% 53.79	10.94	10.33	0.5788	8.2408
Basic Earnings Per Share	81.25% -0.03	-0.16	-0.13	-0.16	-0.16
Diluted Earnings Per Share	81.25% -0.03	-0.16	-0.13	-0.16	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-